A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

Clinical trial NCT03553563 · COMPLETED

Trial details

NCT number: NCT03553563
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Reflux Esophagitis Gastric Ulcer Duodenal Ulcer

Start date: 2018-07-24
Primary completion: 2022-12-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.